Oncotarget

Oncotarget: Neoantigen Evolution in Head and Neck Tumors

Mar 17, 2021
Researchers explore genomic and neoantigen evolution in head and neck tumors, focusing on primary vs. recurrent/metastatic samples. Study includes 23 patients with varying tumor locations and treatment histories. Findings highlight the impact of recurrent mutations and the potential for anti-tumor immune response based on neoantigens.
Ask episode
Chapters
Transcript
Episode notes